Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial

Renal impairment is frequent in patients with multiple myeloma and is correlated with an inferior prognosis. This analysis evaluates the prognostic role of renal impairment in patients with myeloma treated with bortezomib before and after autologous stem cell transplantation within a prospective ran...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Scheid, Christof, Sonneveld, Pieter, Schmidt-Wolf, Ingo G.H., van der Holt, Bronno, el Jarari, Laila, Bertsch, Uta, Salwender, Hans, Zweegman, Sonja, Blau, Igor Wolfgang, Vellenga, Edo, Weisel, Katja, Pfreundschuh, Michael, Jie, Kon-Siong, Neben, Kai, van de Velde, Helgi, Duehrsen, Ulrich, Schaafsma, M. Ron, Lindemann, Walter, Kersten, Marie José, Peter, Norma, Hänel, Mathias, Croockewit, Sandra, Martin, Hans, Wittebol, Shulamiet, Bos, Gerard MJ, van Marwijk-Kooy, Marinus, Wijermans, Pierre, Goldschmidt, Hartmut, Lokhorst, Henk M.
Format: Artigo
Langue:Inglês
Publié: Ferrata Storti Foundation 2014
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4007933/
https://ncbi.nlm.nih.gov/pubmed/23996482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.087585
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires